GlassScriptPhysician profile
James Barry Sanderlin
NPI 1659507721
$1,308.65
in general payments reported to CMS, 2019-2025
19 companies · $50.03 in 2025
The $50.03 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $663 · 2020: $64.02 · 2021: $42.21 · 2022: $489 · 2025: $50.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $50.03.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $50.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $300.00 | 2019-2022 | |
| Boston Scientific Corporation | $248.58 | 2019-2025 | General - Pain Management |
| Medtronic, INC. | $202.42 | 2021-2025 | Intellis Adaptivestim |
| Medtronic USA, INC. | $149.30 | 2019 | |
| Scilex Pharmaceuticals INC. | $55.78 | 2019 | |
| Depuy Synthes Sales INC. | $49.14 | 2019 | |
| Pfizer INC. | $40.52 | 2019 | |
| Abbott Laboratories | $34.99 | 2019-2020 | |
| Allergan, INC. | $33.68 | 2019-2020 | |
| Biodelivery Sciences International, INC. | $28.91 | 2019-2020 | |
| Forte Bio-Pharma LLC | $28.51 | 2019-2020 | |
| Fidia Pharma USA INC. | $26.32 | 2019 | |
| Kaleo, INC. | $26.14 | 2019 | |
| Bioventus LLC | $18.61 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.52 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shionogi INC | $14.24 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.08 | 2019 | |
| Sanofi-Aventis U.S. LLC | $11.87 | 2019 | |
| Zyla Life Sciences, INC. | $11.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Sanderlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.